Trial · NCT07159750
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Monthly Headache Days and Monthly Migraine Days | Through study completion, an average of 2 years | |
| Secondary | HIT-6 | Through study completion, an average of 2 years | Change in HIT-6 (Headache Impact Test) scale, to assess migraine impact. |
| Secondary | MIDAS | Through study completion, an average of 2 years | Change in MIDAS (Migraine Disability Assessment Scale) scale, to assess disability attributed to migraine. |
| Secondary | PGIC | Through study completion, an average of 2 years. | PGIC (Patien Global Impression of Change) scale will be used to assess impression of change in migraine patients. |
| Secondary | BAI | Through study completion, an average of 2 years. | Change in BAI (Beck Anxiety Inventory) scale, to assess anxiety in migraine patients. |
| Secondary | BDI-II | Through study completion, an average of 2 years. | Change in BDI-II (Beck's Depression Inventory, 2nd version) scale, to assess depression in migraine patients. |
| Secondary | MSQ Version 2.1 | Through study completion, an average of 2 years. | Changes in MSQ (Migraine-Specific Quality-of-Life) Version 2.1 scale, to assess patient's quality of life. |
| Secondary | WPAI | Through study completion, an average of 2 years. | Changes in WPAI (Work Productivity and Activity Impairment) questionnaire, to assess how migraine impacts in work and productivity in migraine patients. |
| Secondary | ISI | Through study completion, an average of 2 years. | Changes in ISI (Insomnia Severity Index) scale to assess insomnia in migraine patients. |
| Secondary | ASC-12 | Through study completion, an average of 2 years. | Changes in ASC-12 (Allodynia Symptom Checklist) scale, to assess allodynia in migraine patients. |
| Secondary | m-TOQ | Through study completion, an average of 2 years. | m-TOQ (Migraine Treatment Optimization Questionnaire) scale will be used to assess the effectiveness of migraine treatment. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07159750/registered